More info…
Cypress Bioscience, Inc. announced that it has licensed Alexza Pharmaceutical’s Staccato nicotine technology – a novel electronic multidose delivery technology designed to help people stop smoking.
Cypress acquires worldwide license for Staccato nicotine technology from Alexza Pharma
Previous post: Drugs In Sport: Support Available, Australian Psychological Society
Next post: Footy drugs rule a sham